PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Published Online: 2017-09-27
Journal: Nature•Publisher: Springer Science and Business Media LLC
Authors: Benchun Miao•Bin Wu•Chaoran Cheng•Claire D. Song•Clemens Krepler•Dennie T. Frederick•Gang Chen•Gao Zhang•Genevieve M. Boland•Giorgos C. Karakousis•Gordon Mills•Hezhe Lu•Jeffrey Field•Jephrey Y. Liu•Jianglan Liu•Jie Zhang•Jingwen Zeng•Jonathan Chernoff•Jun Guo•Katrin Sproesser•Keith T. Flaherty•Lawrence W. Wu•Lynn M. Schuchter•Meenhard Herlyn•Min Xiao•Norah Sadek•Ravi K. Amaravadi•Ryan J. Sullivan•Sergio Randell•Shujing Liu•Wei Guo•Wei Xu•Wei Zhang•Wenqun Zhong•Xiaoming Liu•Xiaowei Xu•Yi Hu•Yiling Lu•Yueyao Zhu•Yusheng Cong•Zhi Wei
